Authors: STEIN E ISAACSOHN J STOLTZ R MAZZU A LIU MC LANE C HELLER AH

Citation: E. Stein et al., EFFICACY AND SAFETY OF 0.8 MG DOSAGE OF CERIVASTATIN, A NOVEL HMG-COAREDUCTASE INHIBITOR, Journal of the American College of Cardiology, 31(2), 1998, pp. 281-281

Authors: BLACK HR GRAFF A SHUTE D STOLTZ R RUFF D LEVINE J SHI Y MALLOWS S

Citation: Hr. Black et al., VALSARTAN, A NEW ANGIOTENSIN-II ANTAGONIST FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION - EFFICACY, TOLERABILITY AND SAFETY COMPARED TO AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, LISINOPRIL, Journal of human hypertension, 11(8), 1997, pp. 483-489

Authors: GOLDSTEIN DJ WANG O SAPER JR STOLTZ R SILBERSTEIN SD MATHEW NT

Citation: Dj. Goldstein et al., INEFFECTIVENESS OF NEUROKININ-1 ANTAGONIST IN ACUTE MIGRAINE - A CROSSOVER STUDY, Cephalalgia, 17(7), 1997, pp. 785-790

Authors: GRASELA DM HAWORTH SJ OLSEN SJ HILES C MANITPISITKUL P STOLTZ R

Citation: Dm. Grasela et al., MULTIPLE-DOSE PHARMACOKINETICS AND SAFETY OF BMS-180680 IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 53-53

Authors: SCHWARTZMAN ML LAVROVSKY Y STOLTZ R CONNERS MS ABRAHAM NG

Citation: Ml. Schwartzman et al., ACTIVATION OF NF B AND ONCOGENE MESSENGER-RNA BY 12(R)-HYDROXYEICOSATRIENOIC ACID (12(R)-HETRE) IN MICROVESSEL ENDOTHELIAL-CELLS, The FASEB journal, 8(5), 1994, pp. 10000663-10000663